
Cavapro75 mg
Unimed Unihealth MFG. Ltd.
Irbesartan is an angiotensin II receptor blocker (ARB) with the following evidence-based indications: Hypertension (established/FDA-approved): Treatment of essential hypertension and more.
Irbesartan is an angiotensin II receptor blocker (ARB) with the following evidence-based indications:
Irbesartan is not indicated, and must not be used, during pregnancy (see Contraindications and Pregnancy and Lactation).
| Population | Dose |
|---|---|
| Usual starting/maintenance dose | 150 mg once daily |
| Dose not adequately controlled | May be increased to 300 mg once daily |
| Volume-depleted patients or those >75 years | Consider a starting dose of 75 mg once daily |
| Target dose | Detail |
|---|---|
| 300 mg once daily | The recommended target maintenance dose for renal protection, titrated up from a lower starting dose as tolerated |
Safety and efficacy of Irbesartan for hypertension in pediatric patients under 6 years of age have not been established. Antihypertensive effect has been studied in children 6-16 years of age, but Irbesartan is generally not preferred as a first-line agent in this age group; use only under specialist pediatric guidance.
Irbesartan may be taken with or without food, at approximately the same time each day, exactly as prescribed by a physician. Do not stop or change the dose without medical advice, and discontinue immediately if pregnancy is suspected or confirmed (see Contraindications).
Irbesartan is generally well tolerated. Reported side effects include:
A notable, favorable feature of Irbesartan, as with other ARBs, is a substantially lower incidence of persistent dry cough compared with ACE inhibitors, since it does not affect bradykinin metabolism.
Irbesartan is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.